Last update 30 May 2025

TQC2938

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
TQC 2938, TQC-2938, TQC2938
Target
IL-33R
Action
inhibitors
Mechanism
IL-33R inhibitors(Interleukin-1 receptor-like 1 inhibitors)
Therapeutic Areas
Respiratory DiseasesImmune System DiseasesInfectious Diseases+ [1]
Active Indication
Rhinitis, Allergic, SeasonalPulmonary Disease, Chronic ObstructiveAsthma
Inactive Indication-
Originator Organization
Nanjing Shunxin Pharmaceutical Co., Ltd.Nanjing Shunxin Pharmaceutical Co., Ltd.
Active Organization
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Nanjing Shunxin Pharmaceutical Co., Ltd.Nanjing Shunxin Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with TQC2938
NCT06789289
/ Not yet recruitingPhase 2
A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetic Characteristics of TQC2938 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT06449859
/ Active, not recruitingPhase 1
A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of TQC2938 Injection in Healthy Adult Subjects After Single and Multiple Administration
100 Clinical Results associated with TQC2938
Login to view more data
100 Translational Medicine associated with TQC2938
Login to view more data
100 Patents (Medical) associated with TQC2938
Login to view more data
100 Deals associated with TQC2938
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Rhinitis, Allergic, SeasonalPhase 2
China
Nanjing Shunxin Pharmaceutical Co., Ltd.Nanjing Shunxin Pharmaceutical Co., Ltd.
30 May 2025
Pulmonary Disease, Chronic ObstructivePhase 2
China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
01 Apr 2025
AsthmaPhase 1
China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
13 Jun 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
ATS2025
Phase 1
-
44
xlalffvvor(chboirjoev) = All the adverse events (AE) reported were of grade 1 or 2 asduhjtyyl (ktwuyjirlp )
View more
Positive
16 May 2025
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free